Abstract:Objective To explore the clinical effect of Tanreqing Injection in adjuvant therapy after cardiac surgery. Methods Retrospective study was carried out in 122 patients older than 65 in our department after coronary artery bypass grafting from January 2014 to February 2016. They were divided into two groups at random: the treatment group (61 cases) with postoperative routine application of Cefuroxime combined with Tanreqing Injection preventive treatment, the control group (61 cases) with simple Cefuroxime preventive therapy. The curative effect of Tanreqing injection was observed. The clinical indicators of both groups such as postoperative pulmonary complications, time of use of breathing machine, intensive care time, temperature changes of the patients, time under intensive care, length of hospital stay, and blood test were analyzed. Results The total effective rate of the treatment group (95.08%) was significantly higher than that of the control group (78.69%, P < 0.05). There were significant differences in the time of body temperature lowering to normal, the time of WBC returning to normal, the time of use of breathing machine and the time of hospital stay between the two groups (P < 0.05). Conclusions In the patients over 65 years, the effect of adjuvant treatment with Tanreqing injection is obvious after coronary artery bypass transplantation. It can reduce the postoperative inflammatory response and provide elderly patients with a stable postoperative rehabilitation. Its curative effect still needs further clinical observation.